| Target Price | $14.28 |
| Price | $15.35 |
| Deviation |
6.97%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target Core Laboratories NV 2026 .
The average Core Laboratories NV target price is $14.28.
This is
6.97%
register free of charge
$23.10
50.49%
register free of charge
$10.10
34.20%
register free of charge
|
|
| A rating was issued by 10 analysts: 1 Analysts recommend Core Laboratories NV to buy, 3 to hold and 6 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Core Laboratories NV stock has an average upside potential 2026 of
6.97%
register free of charge
|
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 523.85 | 518.74 |
| 2.76% | 0.98% | |
| EBITDA Margin | 14.45% | 13.87% |
| 0.75% | 4.04% | |
| Net Margin | 5.99% | 6.46% |
| 16.69% | 7.77% |
3 Analysts have issued a sales forecast Core Laboratories NV 2025 . The average Core Laboratories NV sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an Core Laboratories NV EBITDA forecast 2025. The average Core Laboratories NV EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
4 Core Laboratories NV Analysts have issued a net profit forecast 2025. The average Core Laboratories NV net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 0.66 | 0.73 |
| 14.29% | 10.61% | |
| P/E | 21.11 | |
| EV/Sales | 1.55 |
4 Analysts have issued a Core Laboratories NV forecast for earnings per share. The average Core Laboratories NV EPS is
This results in the following potential growth metrics and future valuations:
Core Laboratories NV...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Stifel |
Locked
➜
Locked
|
Locked | Jul 16 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | May 13 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Apr 15 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Mar 12 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Feb 20 2025 |
| Citigroup |
Locked
➜
Locked
|
Locked | Oct 31 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
Stifel:
Locked
➜
Locked
|
Jul 16 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
May 13 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Apr 15 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Mar 12 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Feb 20 2025 |
|
Locked
Citigroup:
Locked
➜
Locked
|
Oct 31 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


